RebrAIn
Pessac
About RebrAIn
RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient's brain using machine learning clinical patient data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: Seed
- Last round: Seed (Mar 2024)
- Website: rebrain.euen
- Phone: [email protected]
Industries & Categories
Hospital, Life Science, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/rebrain-36474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.